The research of chronic insomnia clinical evaluation and optimization of treatment

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16009475

Enrollment

Unknown

Registered

2016-10-18

Start date

2012-04-13

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic insomnia

Interventions

1:alprazolam

2:Zolpidem

3:Trazodone

4:Quetiapine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years; 2. primary insomnia according to the DSM-IV-TR criteria; 3. having sleep difficulties on 3 or more nights per week for at least 6 months.

Exclusion criteria

Exclusion criteria: 1. past or current DSM-IV-TR diagnosis of depressive disorder, dysthymic disorder, bipolar disorder, generalized anxiety disorder, panic disorder, posttraumatic stress disorder, psychotic disorder, or substance use disorder; 2. any significant physical illnesses; 3. significant risk of suicide; 4. pregnancy.

Design outcomes

Primary

Measure	Time frame
the score of PSQI;	—

Countries

China

Contacts

Public ContactLi Huafang

Shanghai Mental Health Center

lhlh_5@163.com+86 021-34773122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026